Executive Summary
A surge of 50 8-K filings on January 8, 2026, primarily from small-cap biotechs, financials, and diverse sectors—notwithstanding the DJ30 focus—reveals patterns of executive turnover (15+ instances), preliminary financial results disclosures (10+), and undisclosed material agreements, with overwhelmingly neutral sentiment but isolated bearish signals from delisting and disposal costs. DJ30 constituents like Walmart, Goldman Sachs, and VF Corp show low-materiality routine filings, indicating blue-chip stability amid broader small-cap churn. Cumulative implications point to early earnings season noise with elevated leadership instability risks, but minimal systemic threat to the DJ30 index.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from January 06, 2026.
Investment Signals(4)
- ▲
urban-gro delisting notice or listing failure [BEARISH] - urban-gro, Inc.
- ▲
Lamb Weston exit/disposal activity costs [BEARISH] - Lamb Weston Holdings, Inc.
- ▲
Cluster of material definitive agreements [BULLISH POTENTIAL] - Acushnet Holdings, Catheter Precision, Limitless X, VEEA, BION Environmental
- ▲
Goldman Sachs financial results disclosure [NEUTRAL TO BULLISH] - Goldman Sachs Group Inc. (DJ30 signal)
Risk Flags(4)
- ▼
Widespread executive turnover (15+ filings) signaling potential leadership instability and governance risks across biotechs, financials, and consumer firms
- ▼
Undisclosed dilution from unregistered equity sales (Limitless X, Ondas, VEEA, VolitionRx) amplifying small-cap vulnerability
- ▼
High uncertainty in 20+ filings with missing details on high-materiality events (e.g., agreements, financials), hindering timely assessment
- ▼
Delisting and disposal cost precedents (urban-gro, Lamb Weston) as early distress indicators in small caps
Opportunities(3)
- ◆
Probe material agreements (Acushnet 8/10 materiality, Catheter Precision/VEEA/Limitless 7/10) for M&A or partnership alpha in underfollowed names
- ◆
Biotech earnings cluster (Invivyd, Xeris, KalVista, Acrivon x2) for beaten-down names with positive surprise potential
- ◆
DJ30 stability (Walmart/GS routine filings) supports overweighting blue-chips amid small-cap churn
Sector Themes(3)
- Biotech/Pharma wave◆
10+ filings with results (Item 2.02), Reg FD, and events, signaling Q4 earnings kickoff and pipeline updates
- Financial services churn◆
Earnings previews (Goldman Sachs, NewtekOne, LPL) paired with officer changes, hinting at sector retooling
- Universal leadership flux◆
Officer changes (Item 5.02) in 30% of filings across sectors, potential precursor to strategic shifts or distress
Watch List(4)
- 👁
urban-gro, Inc. - High-materiality delisting risk with liquidity/valuation threats
- 👁
Lamb Weston Holdings, Inc. - Bearish disposal costs for cost impact and consumer staples signal
- 👁
Acushnet Holdings Corp. - Material agreement details for strategic upside confirmation
- 👁
Officer change clusters (Walmart, Goldman Sachs, LPL Financial) - DJ30/index leadership stability monitor
Filing Analyses(50)
08-01-2026
FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002315, Size: 281 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC.
08-01-2026
Catheter Precision, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000839, Size: 287 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, or other terms are disclosed.
08-01-2026
Global Net Lease, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-001919, Size: 292 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific exhibits are provided. Sector not specified.
08-01-2026
Vanda Pharmaceuticals Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001273, Size: 238 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
08-01-2026
Indivior PLC filed a General Filing (likely Form 8-K) on January 08, 2026 (AccNo: 0001193125-26-006993), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, transaction, or financial impacts provided in the filing summary. All quantitative data and named entities beyond the filer are NOT_DISCLOSED.
08-01-2026
Xeris Biopharma Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001867096-26-000004, Size: 222 KB) reporting under Item 2.02 for Results of Operations and Financial Condition. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a voluntary disclosure of financial results.
08-01-2026
V F CORP filed a Form 8-K on January 08, 2026 (AccNo: 0000103379-26-000004, Size: 213 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, or exhibits are provided. Sector not specified.
08-01-2026
Invivyd, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006997), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific financial metrics, transaction details, or numerical values disclosed in the provided summary. Sector is not specified.
08-01-2026
Soluna Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001493152-26-000891, Size: 333 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, transactions, financial metrics, or named entities beyond the filer are provided. All quantitative data such as transaction values, share counts, or percentages is NOT_DISCLOSED.
08-01-2026
Acrivon Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007007, Size: 331 KB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary.
08-01-2026
Transcat Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001206774-26-000020, Size: 285 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Limitless X Holdings Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000895), reporting under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction values, share counts, dollar amounts, or named entities beyond the filer disclosed. Sector is not specified.
08-01-2026
Frontier Group Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007030, Size: 170 KB) disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on the officer position, appointment/resignation, reasons, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, transaction values, or share counts are mentioned.
08-01-2026
Voyager Therapeutics, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001104659-26-001955, Size: 8 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
08-01-2026
Walmart Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0000104169-26-000008, Size: 258 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or timing are provided. Sector is not specified.
08-01-2026
Lightwave Logic, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001079973-26-000061, Size: 194 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed in the provided summary. Sector is not specified.
08-01-2026
NewtekOne, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001282, Size: 8 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or quantitative data are mentioned.
08-01-2026
LPL Financial Holdings Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007083, Size: 166 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, reason for change, or any quantitative data are disclosed.
08-01-2026
Nuvve Holding Corp. disclosed an officer change event via Form 8-K filed on January 08, 2026 (AccNo: 0001836875-26-000008, Size: 203 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, appointment or resignation status, reasons for change, named individuals, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
08-01-2026
Acrivon Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007077, size 17 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specific content from the filing is provided in the summary. Sector is not specified.
08-01-2026
Lamb Weston Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001679273-26-000002, Size: 143 KB), reporting under Item 2.05 costs associated with exit or disposal activities. No specific details, dollar values, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
08-01-2026
First Northwest Bancorp filed a Form 8-K on January 08, 2026 (AccNo: 0001437749-26-000851, Size: 152 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on the affected individuals, positions, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Ondas Holdings Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002367, Size: 210 KB), reporting under Item 3.02 for Unregistered Sales of Equity Securities, Item 8.01 for Other Events, and Item 9.01 for Financial Statements and Exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or financial metrics disclosed in the provided summary. Sector is not specified.
08-01-2026
COMMUNITY BANCORP /VT filed a Form 8-K on January 08, 2026 (AccNo: 0001654954-26-000181, size 152 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are provided in the filing summary.
08-01-2026
Apple iSports Group, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001477932-26-000095, Size: 128 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, names, reasons for change, or quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
CervoMed Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000883, size 162 KB), reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This appears to be a multi-item, voluntary disclosure related to material non-public information shared selectively, with attached exhibits. No core event details, transaction values, financial metrics, or other specifics are provided in the filing summary.
08-01-2026
Datavault AI Inc. filed a Form 8-K on January 08, 2026, under Item 8.01 Other Events, with Accession Number 0001104659-26-002125 and file size of 187 KB. This appears to be a single-item voluntary disclosure, as no other items or specific event details are mentioned. No financial metrics, transaction values, or strategic implications are disclosed.
08-01-2026
Heritage Distilling Holding Company, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001788230-26-000002, Size: 185 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the Regulation FD disclosure content, core event, transaction details, financial statements, or exhibits are provided in the filing summary. Sector is not specified.
08-01-2026
EDUCATIONAL DEVELOPMENT CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001185185-26-000075, Size: 237 KB), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This multi-item filing pertains to financial results in the US market. No specific financial metrics, transaction values, or other quantitative data are mentioned.
08-01-2026
Kimball Electronics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001606757-26-000004, Size: 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are provided in the filing summary. Sector not specified.
08-01-2026
Verastem, Inc. filed a Form 8-K on January 08, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Filing details include AccNo: 0001104659-26-002135 and Size: 9 MB. Sector is not specified.
08-01-2026
Goldman Sachs Group Inc filed a Form 8-K on January 8, 2026 (AccNo: 0000886982-26-000004, Size: 3 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events). This is a financial results disclosure from the US SEC. No specific financial metrics, transaction details, or numerical data provided in the filing summary.
08-01-2026
Acushnet Holdings Corp. filed a Form 8-K on 2026-01-08 (AccNo: 0001672013-26-000007, Size: 501 KB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's nature, parties, terms, value, or financial impacts are disclosed. This is a multi-item filing for a Material Event from US SEC source; sector not specified.
08-01-2026
Vita Coco Company, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001628280-26-001348, Size: 198 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, name, appointment/resignation status, reasons, or any quantitative data are disclosed in the provided filing summary.
08-01-2026
MID PENN BANCORP INC disclosed an officer change via Form 8-K filed on January 08, 2026 (AccNo: 0000879635-26-000007, Size: 494 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, nature of change, reasons, or compensation are provided.
08-01-2026
V2X, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001628280-26-001359, Size: 181 KB), disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer involved, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the available information. Sector is not specified.
08-01-2026
BION ENVIRONMENTAL TECHNOLOGIES INC filed a Form 8-K on January 08, 2026 (AccNo: 0001079973-26-000065, Size: 182 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, counterparties, financial terms, or exhibits are disclosed in the provided summary. Sector not specified.
08-01-2026
VEEA INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002557, Size: 250 KB), reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific details on the transactions, counterparties, or values disclosed in the provided information. Sector is not specified.
08-01-2026
Exodus Movement, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007775, Size: 151 KB) reporting under Item 8.01 Other Events. No details on the core event, transaction, financial impact, or other specifics are provided in the filing summary. All quantitative data, named entities beyond the filer, and material implications are NOT_DISCLOSED.
08-01-2026
INNO HOLDINGS INC. filed a Form 8-K on January 08, 2026, reporting under Item 8.01 Other Events. The filing accession number is 0001493152-26-000980 with a size of 203 KB. No details on the specific event, transaction values, financial impacts, or other quantitative data are disclosed.
08-01-2026
SilverBox Corp V filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002148, size: 261 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals involved, positions affected, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
urban-gro, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001213900-26-002552, Size: 194 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the delisting trigger, financial impacts, transaction values, or sector are disclosed. This represents a material compliance event with bearish implications for liquidity and valuation.
08-01-2026
KalVista Pharmaceuticals, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007801, Size: 2 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure for a US biotech company, but specific revenue, earnings, or other metrics are NOT_DISCLOSED. Sector is not specified.
08-01-2026
Planet 13 Holdings Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000891, Size: 150 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any compensation arrangements are provided in the filing summary. Sector is not specified.
08-01-2026
INTELLIGENT BIO SOLUTIONS INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000984, Size: 202 KB) under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector not specified.
08-01-2026
SS Innovations International, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002572, Size: 311 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.
08-01-2026
VolitionRx Ltd filed a Form 8-K on January 8, 2026 (AccNo: 0001477932-26-000107, size 737 KB), reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial impacts disclosed in the provided summary. Sector not specified.
08-01-2026
Gabelli Dividend & Income Trust filed a Form 8-K on January 8, 2026 (AccNo: 0001829126-26-000118, Size: 242 KB) under Item 8.01 Other Events announcing a dividend. No specific details on dividend amount, record date, ex-dividend date, payment timeline, or eligibility are disclosed. Sector is not specified.
Get daily alerts with 4 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC